Imuno-2865™ (120 ct)

Enhancing Your Animals' Natural Protection and Ability To Heal

Proper immune function is the cornerstone of health and the foundation of normal physiologic functioning in ALL organ systems. Imuno-2865� is a first responder natural supplement that supports health and wellness by reducing inflammation and promoting normalization of the immune system.

120 Capsules Per Bottle
Product Code: AN146
Price for US Customers Only

Imuno-2865� (Natramune�) is a naturally obtained hemicellulose (high molecular weight polysaccharide complex) and fatty acid mixture extracted from natural sources (Gramineae, Poaceae, Dioscoreaceae family of plants and/or several species of mushrooms).

Many animals with chronic disease states have poorly functioning immune responses underlying their problems. By enhancing immune function, a critical adjunctive therapeutic goal in the management of all disease states, Imuno-2865� promotes effective natural killer cell cytotoxicity, phagocytosis and nitric oxide production to sustain proper immune function. Imuno-2865� is supported by multiple human clinical studies as a functional ingredient in overall immune system support, immuno stimulation and boosting of natural killer cell activity. 1 - 3

  • Imuno-2865� is a naturally obtained hemicellulose (high molecular weight polysaccharide complex) and fatty acid mixture which has been extracted from graminiae, poaceae, dioscoreaceae, and several species of mushrooms using a protected proprietary process.
  • Rice bran and mushrooms are broken down during a "pre-digestion" process into glyconutrients such as arabinoxylan and beta-glucan which increase interferon-y production by peripheral blood mononuclear cells, acting synergistically with interleukin-2 to increase Natural Killer (NK) cell activity and production of tumor necrosis factor-alpha, as well as enhancing the activity of other important immune cells such as B-cells and T-cells.
  • Arabinogalactan-enhances beneficial gut microflora by increasing short-chain fatty acid production (primarily butyrate)which is essential for proper colon health and is the preferred substrate for energy generation by colonic epithelial cells.

1. Chavoustie S, Perez P, Fletcher M, Maher K, Mitrani A, Thomas R. Pilot Study: Effect of PDS-2865� on Natural Killer Cell Cytotoxicity. Journal of the American Nutraceutical Association 2003; 6(2): 39-42.

2. Weeks B., et. Al. Natramune and PureWay-C reduce xenobiotic-induced human T-cell a5b1 integrin-mediated adhesion to fibronectin. Med Sci Monit 2008; 14(12): BR1-7.

3. Levine, G., Levin, M., et. al. Evaluation of Imuno-2865 on General Rehabilitation Outcomes and Cytokines Profile Analysis in Abandoned Neonatal Harbor Seals (Phoca vitulina) and Malnourished Weanling Elephant Seals (Mirounga angustirostris). IAAAM 45th Annual Conference Proceedings Gold Coast, Australia.

Baseline Dosages:

WEIGHT (LBS) DAILY USE
Less than 5 Contact Us for Dosage Guidelines
5-15 1/2 Capsule
16-50 1 Capsule
51-100 1 Capsule A.M. and 1 Capsule P.M.
101-200 1 Capsule A.M. and 2 Capsules P.M.
201-300 2 Capsules A.M. and 2 Capsules P.M.
301-500 2 Capsules A.M. and 3 Capsules P.M.
501+ Contact Us for Dosage Guidelines

*The above doses are for preventative health. For specific diseases, please contact Animal Necessity for a free consultation.

*If you animal has any known allergies to pollen, grass or plants, please contact Animal Necessity for dosing and information.

"As a clinician it is comforting to have something as an adjunct in our older patients that we saw behaviorally and clinically helping even before some of the data came in."

- Dr. Maya Rodriguez, using Imuno-2865 as an immune adjunct supplement."
Serving Size: 2
//
Servings Per Bottle: 60
//
Capsules Per Bottle: 120
Active Ingredients Amount Per Serving
PDS-2865� Proprietary Blend
Polysaccharide Complex Extract
Rice Flour
Rice Bran
Microcrystalline cellulose
Grapeseed Extract
1000 mg
Other Ingredients: Gelatin, Magnesium, Stearate
Extra Information:
PDS-2865� is a registered trademark of Innovation Laboratories, Inc. (patent pending)